Crossmark

Outcomes of upfront plerixafor use for mobilization in germ cell tumor patients

Crossref DOI link: https://doi.org/10.1016/j.htct.2023.12.008

Published Print: 2024-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Cohen, Jaimie https://orcid.org/0000-0002-3061-4519
Shah, Shreya https://orcid.org/0000-0002-2742-4351
Piedra, Katrina https://orcid.org/0000-0002-7053-5372
Shalhoub, Sila https://orcid.org/0000-0002-5355-0124
Benjamin, Cara https://orcid.org/0009-0005-2906-8775
Pereira, Denise https://orcid.org/0000-0002-1992-7899
License Information

Text and Data Mining valid from 2024-11-01

Text and Data Mining valid from 2024-11-01

Version of Record valid from 2024-02-14
More Information

This article is maintained by: Elsevier

Article Title: Outcomes of upfront plerixafor use for mobilization in germ cell tumor patients

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2023.12.008

Content Type: article

Copyright: © 2024 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U.